University Hospitals Cleveland Medical Center is a large not-for-profit academic medical complex in Cleveland, Ohio, United States. University Hospitals Cleveland Medical Center is a major affiliate hospital of Case Western Reserve University.

There are 1,032 beds in University Hospitals of Cleveland.

During the past decade, University Hospitals of Cleveland conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 91 clinical trials were completed, i.e. on average, 73.4% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 49 clinical trials were completed. i.e. 104.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals of Cleveland" #1 sponsor was "University Hospitals Cleveland Medical Center" with 33 trials, followed by "Radiation Therapy Oncology Group" with 32 trials sponsored, "Abbott Medical Devices" with 13 trials sponsored, "Boston Scientific Corporation" with 12 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 12 trials sponsored. Other sponsors include 241 different institutions and companies that sponsored additional 160 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals of Cleveland" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "University Hospitals Cleveland Medical Center" with 8 trials as a collaborator, "Abbott" with 3 trials as a collaborator and "Clinical Trials in Organ Transplantation" with 3 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 133 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals of Cleveland" are "HIV Infections" (11 trials), "Pulmonary Hypertension" (11 trials), "Coronary Artery Disease" (8 trials), "Head and Neck Cancer" (8 trials) and "Prostate Cancer" (8 trials). Many other conditions were trialed in "University Hospitals of Cleveland" in a lesser frequency.

Most popular intervention types in "University Hospitals of Cleveland" are "Drug" (218 trials), "Device" (66 trials), "Radiation" (34 trials), "Procedure" (32 trials) and "Other" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "radiation therapy" (29 trials), "Carboplatin" (9 trials), "conventional surgery" (8 trials) and "cisplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals of Cleveland" are 316 trials for "All" genders, 21 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospitals of Cleveland". undefined are not yet recruiting, 36 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 221 completed trials in University Hospitals of Cleveland, 2 suspended trials, and 43 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals of Cleveland, 37 "Phase 1" clinical trials were conducted, 96 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 64 trials that are defined as “Not Applicable".